SCHEMBL9425151

SCHEMBL9425151

CNC(Cc1ccccc1NC(=O)C(C)(C)C)c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.42
CETP P11597 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.39
TSHR P16473 2/20 0.38
POLB P06746 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
TOP2A P11388 1/20 0.37
CYP1A2 P05177 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8946015 0.86 KDM4E (0.42) KDM4EHTTLMNATSHRNOS3
SCHEMBL9425200 0.82 CETP (0.42) CETPKDM4ELMNATSHRPOLB
SCHEMBL9001648 0.81 CETP (0.46) CETPLMNATSHRNOS3NOS1
SCHEMBL9425047 0.79 TSHR (0.49) CYP2C19CETPLMNATSHRCYP1A2
SCHEMBL9582929 0.79 CETP (0.43) CETPHTTTSHRPOLBNOS3
SCHEMBL9582457 0.78 PDK1 (0.43) CETPLMNATSHRNOS3NOS1
SCHEMBL9425172 0.76 MAPT (0.45) CETPHTTTSHRPOLBL3MBTL1
SCHEMBL9425495 0.75 CETP (0.40) CETPKDM4EHTTTSHRL3MBTL1
SCHEMBL9425144 0.75 CETP (0.40) CETPLMNATSHRNOS3NOS1
SCHEMBL8945812 0.74 CETP (0.39) CETPTSHRL3MBTL1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292760-A 4-heteroaryl-1,3-benzodiazepines and 2-substituted-α-(heteroaryl)benzeneethanamines HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-03-08 US disclosed
EP-0322582-A2 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-07-05 EP disclosed